Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1110585 | 0.98 | ALDH1A1 (0.42) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL9790 | 0.98 | ALDH1A1 (0.45) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL2229127 | 0.98 | ALDH1A1 (0.45) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL2417 | 0.98 | ALDH1A1 (0.45) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21752843 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21752841 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| Ammonia Solution, Strong SCHEMBL5698223 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21752977 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21752846 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL3653844 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210222118-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2021-07-22 | — | — | US | claimed |
| EP-3841214-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2021-06-30 | — | — | EP | claimed |
| CN-112888790-A | Legionella carbon-free culture medium | 英国卫生与社会保障部 | 2021-06-01 | — | — | CN | claimed |
| WO-2020039213-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2020-02-27 | — | — | WO | claimed |
| US-11926651-B2 | Polypeptide construct comprising fragments of allergens | Worg Pharmaceuticals (Zhejiang) Co., Ltd. (CN) | 2024-03-12 | — | — | US | disclosed |
| US-20210222118-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2021-07-22 | — | — | US | disclosed |
| EP-3841214-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2021-06-30 | — | — | EP | disclosed |
| CN-112888790-A | Legionella carbon-free culture medium | 英国卫生与社会保障部 | 2021-06-01 | — | — | CN | disclosed |
| WO-2020039213-A1 | CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA | Secretary of State for Health and Social Care (GB) | 2020-02-27 | — | — | WO | disclosed |
| US-20190248844-A1 | POLYPEPTIDE CONSTRUCT COMPRISING FRAGMENTS OF ALLERGENS | Worg Pharmaceuticals (Zhejiang) Co., Ltd. (CN) | 2019-08-15 | — | — | US | disclosed |
| EP-3515484-A1 | POLYPEPTIDE CONSTRUCT COMPRISING FRAGMENTS OF ALLERGENS | BIOMAY AG (AT) | 2019-07-31 | — | — | EP | disclosed |
| CN-108404118-A | New application of human milk agglutinin subtype protein | 张建宁 | 2018-08-17 | — | — | CN | disclosed |
| EP-2081589-B1 | COMPLEMENTATION OF FACTOR XI DEFICIENCY BY FACTOR V MUTANTS | CRUCELL HOLLAND BV (NL) | 2010-10-06 | — | — | EP | disclosed |
| US-20100144620-A1 | COMPLEMENTATION OF FACTOR XI DEFICEINCY BY FACTOR V MUTANTS | CRUCELL HOLLAND B.V. (NL) | 2010-06-10 | — | — | US | disclosed |
| EP-2081589-A2 | COMPLEMENTATION OF FACTOR XI DEFICIENCY BY FACTOR V MUTANTS | Crucell Holland B.V. (NL) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008059009-A2 | FACTOR V MUTANTS FOR HEMOSTASIS IN HEMOPHILIA | CRUCELL HOLLAND B.V. (NL) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008059041-A2 | COMPLEMENTATION OF FACTOR XI DEFICIENCY BY FACTOR V MUTANTS | CRUCELL HOLLAND B.V. (NL) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008059043-A2 | COMBINATION OF COAGULATION FACTOR VIII WITH APC-RESISTANT FACTOR V | CRUCELL HOLLAND B.V. (NL) | 2008-05-22 | — | — | WO | disclosed |
| CN-1083824-C | Synthetic compound having cardiovascular pharmacological activity and its preparing process | XU JINGFENG (CN) | 2002-05-01 | — | — | CN | disclosed |
| CN-1249295-A | Synthetic compound having cardiovascular pharmacological activity and its preparing process | XU JINGFENG (CN) | 2000-04-05 | — | — | CN | disclosed |